|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―22 |
Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review |
Abdul Moeed, Muhammad Omar Larik, Muhammad Ahmed Ali Fahim, Hafsah Alim Ur Rahman, Lubna Najmi, Mah I Kan Changez, et al. (+2) Muhammad Moiz Javed, Md Al Hasibuzzaman |
2 |
[GO] |
2024―Jun―19 |
In-hospital outcomes in COVID-19 patients with non-alcoholic fatty liver disease by severity of obesity: Insights from national inpatient sample 2020 |
Sashwath Srikanth, Vibhor Garg, Lakshmi Subramanian, Jyoti Verma, Hansika Sharma, Harroop Singh Klair, et al. (+9) Shrenil A Kavathia, Jithin Kolli Teja, Nikhil Sai Vasireddy, Kumar Anmol, Dhanush Kolli, Shruti Sanjay Bodhankar, Sobya Hashmi, Shaylika Chauhan, Rupak Desai |
3 |
[GO] |
2024―Apr―24 |
Spectrum of COVID-19 induced liver injury: A review report |
Lokjan Singh, Anil Kumar, Maya Rai, Bibek Basnet, Nishant Rai, Pukar Khanal, et al. (+4) Kok-Song Lai, Wan-Hee Cheng, Ahmed Morad Asaad, Shamshul Ansari |
4 |
[GO] |
2024―Apr―24 |
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic |
Arghya Samanta, Moinak Sen Sarma |
5 |
[GO] |
2024―Feb―27 |
Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease |
Lung-Yi Mak, Matthew Shing Hin Chung, Xue Li, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, Celine Sze Ling Chui, et al. (+9) Franco Wing Tak Cheng, Esther Wai Yin Chan, Ching Lung Cheung, Ivan Chi Ho Au, Xi Xiong, Wai-Kay Seto, Man-Fung Yuen, Carlos King Ho Wong, Ian Chi Kei Wong |
6 |
[GO] |
2024―Jan―23 |
Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage |
Jorge Quarleri, M Victoria Delpino |
7 |
[GO] |
2023―Apr―20 |
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations |
Romina Roshanshad, Amirhossein Roshanshad, Reza Fereidooni, Mahnaz Hosseini-Bensenjan |
8 |
[GO] |
2023―Apr―20 |
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States |
Inkyu S Lee, Kenji Okumura, Ryosuke Misawa, Hiroshi Sogawa, Gregory Veillette, Devon John, et al. (+3) Thomas Diflo, Seigo Nishida, Abhay Dhand |
9 |
[GO] |
2023―Mar―22 |
May 2022 acute hepatitis outbreak, is there a role for COVID-19 and other viruses? |
Reem Elbeltagi, Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Osama Toema |
10 |
[GO] |
2023―Mar―22 |
COVID-19 and liver dysfunction in children: Current views and new hypotheses |
Yang-Fang Yun, Zhi-Yuan Feng, Jing-Jing Zhang |
11 |
[GO] |
2023―Feb―24 |
Hospitalizations for alcoholic liver disease during the COVID-19 pandemic increased more for women, especially young women, compared to men |
John Patterson Campbell, Vinay Jahagirdar, Adel Muhanna, Kevin F Kennedy, John H Helzberg |
12 |
[GO] |
2023―Jan―15 |
Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection |
Peter Liptak, Lenka Nosakova, Robert Rosolanka, Lubomir Skladany, Peter Banovcin |
13 |
[GO] |
2023―Jan―15 |
Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study |
Arunkumar Krishnan, Ruhee A Patel, Yousaf Bashir Hadi, Diptasree Mukherjee, Sarah Shabih, Shyam Thakkar, et al. (+3) Shailendra Singh, Tinsay A Woreta, Saleh A Alqahtani |
14 |
[GO] |
2022―Dec―23 |
Liver chemistries in severe or non-severe cases of COVID-19: A systematic review and meta-analysis |
Xuan Dong, Dan-Yi Zeng, Qing-Qing Xing, Mei-Zhu Hong, Jin-Shui Pan |
15 |
[GO] |
2022―Nov―25 |
Liver test abnormalities in asymptomatic and mild COVID-19 patients and their association with viral shedding time |
Si-Yi Yu, Jia-Rong Xie, Jun-Jun Luo, Hong-Peng Lu, Lei Xu, Jun-Jie Wang, Xue-Qin Chen |
16 |
[GO] |
2022―Oct―27 |
Alcohol use disorder and liver injury related to the COVID-19 pandemic |
Giuseppe Marano, Gianandrea Traversi, Eleonora Gaetani, Roberto Pola, Angelo Emilio Claro, Marianna Mazza |
17 |
[GO] |
2022―Aug―26 |
Secondary sclerosing cholangitis after critical COVID-19: Three case reports |
Juan M Mayorquín-Aguilar, Aldo Lara-Reyes, Luis Alberto Revuelta-Rodríguez, Nayelli C Flores-García, Astrid Ruiz-Margáin, Marco Antonio Jiménez-Ferreira, Ricardo Ulises Macías-Rodríguez |
18 |
[GO] |
2022―Jul―27 |
Efficacy and safety of COVID-19 vaccination in patients with cirrhosis |
Vladimir Ivashkin, Albina Ismailova, Ksenia Dmitrieva, Roman Maslennikov, Maria Zharkova, Salekh Aliev, et al. (+2) Vyacheslav Bakhitov, Vadim Marcinkevich |
19 |
[GO] |
2022―Jun―20 |
COVID-19 liver and gastroenterology findings: An in silico analysis of SARS-CoV-2 interactions with liver molecules |
Gabrielle Caroline Peiter, Cristiano de Bem Torquato de Souza, Lucca Miketen de Oliveira, Luis Gustavo Pagliarin, Valentina Nunes Fontoura dos Anjos, Filipe Antônio França da Silva, et al. (+2) Fabrício Freire de Melo, Kádima Nayara Teixeira |
20 |
[GO] |
2022―Jun―20 |
Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity |
Tarun Sahu, Babita Pande, Manasa PL, Henu Kumar Verma |
21 |
[GO] |
2022―Jun―20 |
Clinical outcomes of coronavirus disease 2019 in liver transplant recipients |
Muhammad Shafiq, Cheryl Gibson |
22 |
[GO] |
2022―Feb―21 |
COVID-19 and liver disease: Are we missing something? |
Tarana Gupta |
23 |
[GO] |
2022―Jan―21 |
COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study |
Alessandra Zannella, Silvia Fanella, Massimo Marignani, Paola Begini |
24 |
[GO] |
2022―Jan―21 |
Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2 |
Rosangela Passos de Jesus, Jozélio Freire de Carvalho, Lucivalda Pereira Magalhães de Oliveira, Carla de Magalhães Cunha, Thaisy Cristina Honorato Santos Alves, Sandra Tavares Brito Vieira, et al. (+2) Virginia Maria Figueiredo, Allain Amador Bueno |
25 |
[GO] |
2021―Dec―27 |
Liver function in COVID-19 infection |
Dagmara Przekop, Ewa Gruszewska, Lech Chrostek |
26 |
[GO] |
2021―Dec―27 |
COVID-19 and the liver: A brief and core review |
Bircan Kayaaslan, Rahmet Guner |
27 |
[GO] |
2021―Dec―27 |
Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases |
Man Fai Law, Rita Ho, Kimmy Wan Tung Law, Carmen Ka Man Cheung |
28 |
[GO] |
2021―Dec―27 |
Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19 |
Gergana Taneva, Dimitar Dimitrov, Tsvetelina Velikova |
29 |
[GO] |
2021―Dec―27 |
Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States |
Adalberto Jose Gonzalez, Nikhil Kapila, Emmanuel Thomas, Antonio Pinna, Andreas Tzakis, Xaralambos Bobby Zervos |
30 |
[GO] |
2021―Oct―22 |
Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units |
Amr Salah Omar, Rasha Kaddoura, Bassant Orabi, Samy Hanoura |
31 |
[GO] |
2021―Oct―22 |
Liver and COVID-19: From care of patients with liver diseases to liver injury |
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo |
32 |
[GO] |
2021―Oct―22 |
Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects |
Carmelo Loinaz-Segurola, Alberto Marcacuzco-Quinto, Mario Fernández-Ruiz |
33 |
[GO] |
2021―Sep―18 |
Drug-induced liver injury and COVID-19: A review for clinical practice |
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt |
34 |
[GO] |
2021―Sep―18 |
Coronavirus disease 2019 and non-alcoholic fatty liver disease |
Francesco Bellanti, Gianluigi Vendemiale |
35 |
[GO] |
2021―Sep―18 |
Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2 |
Emily E Currier, Mohamad Dabaja, Syed-Mohammed Jafri |
36 |
[GO] |
2021―Aug―20 |
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence |
Prajna Anirvan, Shivaram P Singh, Alexa Giammarino, Sanjaya K Satapathy |
37 |
[GO] |
2021―Aug―20 |
Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study |
Ali Madian, Ahmed Eliwa, Hytham Abdalla, Haitham A Azeem Aly |
38 |
[GO] |
2021―Jul―23 |
Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C |
Syed Tabish Rehman, Hareem Rehman, Shahab Abid |
39 |
[GO] |
2021―May―20 |
COVID-19 and the liver: What do we know so far? |
Prashant Nasa, George Alexander |
40 |
[GO] |
2020―Dec―18 |
Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome - what we know so far |
Prajna Anirvan, Pankaj Bharali, Mrinal Gogoi, Paul J Thuluvath, Shivaram P Singh, Sanjaya K Satapathy |
41 |
[GO] |
2020―Oct―24 |
Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports |
Felipe Alconchel, Pedro A Cascales-Campos, Jose A Pons, María Martínez, Josefa Valiente-Campos, Urszula Gajownik, et al. (+7) María L Ortiz, Laura Martínez-Alarcón, Pascual Parrilla, Ricardo Robles, Francisco Sánchez-Bueno, Santiago Moreno, Pablo Ramírez |
42 |
[GO] |
2020―Sep―19 |
Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study |
Vishnu Charan Suresh Kumar, Prateek Suresh Harne, Samiran Mukherjee, Kashvi Gupta, Umair Masood, Anuj Vikrant Sharma, et al. (+3) Jivan Lamichhane, Amit Singh Dhamoon, Bishnu Sapkota |
43 |
[GO] |
2020―Aug―24 |
Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm? |
Carlos Antunes Brito, Fabio Marinho Barros, Edmundo Pessoa Lopes |
44 |
[GO] |
2020―Aug―24 |
Management of hepatitis C in children and adolescents during COVID-19 pandemic |
Maria Pokorska-Śpiewak, Mateusz Śpiewak |